Protalix BioTherapeutics, Inc.

PLX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Apr 16, 2018 FORM 8-K
CT ORDER Apr 3, 2018
DEFA14A Apr 2, 2018 DEFA14A
DEFA14A Mar 23, 2018 DEFA14A
8-K Mar 21, 2018 FORM 8-K
DEF 14A Mar 6, 2018 DEFINITIVE PROXY STATEMENT
10-K Mar 6, 2018 FORM 10-K
8-K Mar 6, 2018 FORM 8-K
PRE 14A Feb 23, 2018 PRE 14A
SC 13G/A Feb 13, 2018 SCHEDULE 13G AMENDMENT 1
SC 13G/A Feb 13, 2018 AMENDMENT TO SCHEDULE 13G
SC 13G/A Feb 12, 2018 AMENDMENT NO. 2 TO SCHEDULE 13G
SC 13G Feb 9, 2018 SC 13G
8-K Jan 31, 2018 8-K
SC 13G/A Jan 25, 2018 SC 13G/A
8-K Jan 5, 2018 FORM 8-K
8-K Dec 1, 2017 FORM 8-K
8-K Nov 27, 2017 FORM 8-K
8-K Nov 13, 2017 8-K
10-Q Nov 8, 2017 FORM 10-Q
8-K Nov 8, 2017 FORM 8-K
8-K Oct 20, 2017 8-K
8-K Oct 19, 2017 FORM 8-K
DEFA14A Oct 10, 2017 DEFA14A
DEFA14A Sep 18, 2017 DEFA14A
← Newer Page 15 of 38 · 935 filings Older →